Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

bendamustine

bendamustine
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Treanda SOLUTION, INTRAVENOUS 90 mg/mL      
Bendeka SOLUTION, INTRAVENOUS 100 mg/4 mL      
VIEW MORE Antineoplastic Agents
CLASS
100000
Comments:

Treanda\Bendeka is classified as formulary, restricted to oncology. Due to its high cost, deferral to the outpatient setting should be explored. If ordered, contact a member of pharmacy administration.

Treanda anticipated to be manufacturer discontinued in 2016 to be replaced by the reformulation Bendeka.

Reviewed: July 29, 2008 & 22 March 2016 (Bendeka)

Last updated: Apr. 11, 2024






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved